BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 2561449)

  • 21. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
    Miot F; Erneux C
    Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential recognition of calmodulin-enzyme complexes by a conformation-specific anti-calmodulin monoclonal antibody.
    Hansen RS; Beavo JA
    J Biol Chem; 1986 Nov; 261(31):14636-45. PubMed ID: 3021748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
    Craven PA; Neidig M; DeRubertis FR
    Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
    Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
    Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drosophila cyclic nucleotide phosphodiesterases.
    Davis RL; Kauvar LM
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():393-402. PubMed ID: 6326533
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular interaction between cAMP and calcium in calmodulin-dependent cyclic nucleotide phosphodiesterase system.
    Sharma RK; Kalra J
    Clin Invest Med; 1994 Aug; 17(4):374-82. PubMed ID: 7982300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 32. Calmodulin regulation of testicular cyclic nucleotide phosphodiesterases.
    Purvis K; Hansson V
    Int J Androl; 1980 Dec; 3(6):713-8. PubMed ID: 6259062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of a 5.3-S calmodulin-deficient 3':5'-cyclic nucleotide phosphodiesterase from cardiac muscle.
    Mohindru A; Rhoads AR
    Biochem J; 1982 Aug; 205(2):427-35. PubMed ID: 6291508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases.
    Beltman J; Sonnenburg WK; Beavo JA
    Mol Cell Biochem; 1993 Nov; 127-128():239-53. PubMed ID: 7935355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Two forms of cyclic nucleotide phosphodiesterase and Ca-dependent protein regulator from rabbit skeletal muscles].
    Lazarevich VG; Men'shikov MIu; Tkachuk VA
    Biokhimiia; 1979 Oct; 44(10):1842-51. PubMed ID: 228768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE; Barron B
    Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
    Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
    Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
    Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
    Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites.
    Erneux C; Miot F
    Methods Enzymol; 1988; 159():520-30. PubMed ID: 2842616
    [No Abstract]   [Full Text] [Related]  

  • 40. Ca(2+)/calmodulin-dependent cyclic nucleotide phosphodiesterase in cGMP metabolism in rabbit parotid acinar cells.
    Sairenji N; Satoh K; Sugiya H
    Biomed Res; 2006 Feb; 27(1):37-44. PubMed ID: 16543664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.